Eligo Bioscience, a gene-editing company focused on addressing diseases driven by the expression of bacterial genes from the microbiome, has announced a successful $30 million Series B funding round, led by Sanofi Ventures.
Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
The patent supports therapeutic interventions in serious skin disorders. This work provides opportunities to leverage the skin s immune system for oncological, vaccination or desensitization applications.